Measurement of lipoprotein (a): Comparison of macra™ and imubind® methods

Annals of Clinical and Laboratory Science

Volumn 26, Issue 4, 1996, Pages 329-339

  Stroop, Davis M ^a,b   Glueck, Charles J ^b   McCray, Carol ^b   Speirs, James ^a   Schumacher, Harold R ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; BLOOD BANKS; CALIBRATION; CHILD; CITRIC ACID; EDETIC ACID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEIN(A); MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; STATISTICS; TIME FACTORS;

EID: 0029901704     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Glueck CJ, Glueck HI, Tracy T, Speirs J, McCray C, Stroop D. Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators and P-dimer. Metabolism 1993;42:236-46.
2. Gaubatz JW, Heideman C, Gotto AM, Morrisett JD. Human plasma lipoprotein(a), structural properties. J Biol Chem 1983;258:4582-9.
3. Berg K. A new serum type system in man: the Lp(a) system. Acta Pathol Microbiol Scand 1963;59:369-82.
4. Dahlén G, Frick MH, Berg K, Vallen M, Wiljasallo M. Further studies of Lp(a) lipoprotein/ pre-, lipoprotein in patients with coronary heart disease. Clin Genet 1975;8:183-9.
5. Rhoads GG, Dahlén G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986;256: 2540-4.
6. Dahlén GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM Association of levels of lipoprotein Lp(a), plasma lipids and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986;74: 758-65.
7. Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, Kreuzer H, Seidel D. The association between serum Lp(a) concentrations and angiographically assessed coronary arteriosclerosis. Atherosclerosis 1986;62:24957.
8. Genest J Jr, Jenner JL, McNamara JR, Ordovas JM, Silberman SR, Wilson PFW, Schafer EJ. Prevalence of lipoprotein(a) [Lp(a)] excess in coronary artery disease. Am J Cardiol 1991;67: 1039-15.
9. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease: A prospective case-control study in a general population sample of middle-aged men. BMJ 1990;301:1248-51.
10. Genest J Jr, McNamara JR, Ordovas JM, Jenner JL, Silberman SR, Anderson KM, Wilson PWF, Salem DM, Schafer EJ. Lipoprotein cholesterol, apolipoprotein A-l and B and lipoprotein(a) abnormalities in men with premature coronary artery disease. J Am Coll Cardiol 1992; 19:792-802.
11. Houlston R, Quiney J, Mount J, Watts GF, Lewis B. Lipoprotein(a) and coronary heart disease in familial hypercholesterolemia. Lancet 1988;11:405.
12. Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo Bon G, Qunici GB. Lipoprotein Lp(a) and the risk of myocardial infarction. Atherosclerosis 1981;38:51-61.
13. Albers JJ, Adolphson JL, Hazzard WR. Radioimmunoassay of human plasma Lp(a) lipoprotein. J Lipid Res 1977;18:331-8.
14. Albers JJ, Hazzard WR. Immunochemical quantification of human plasma Lp(a) lipoprotein. Lipids 1974;9:15-26.
15. Albers JJ, Cabana VG, Warnick GR, Hazzard WR. Lp(a) lipoproteins: relationship to sinking pre-beta lipoprotein, hyperlipoproteinemia and apolipoprotein B. Metabolism 1975;24(9): 1047-54.
16. Vessby B, Kostner G, Lithel H, Thomis J. Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a). Atherosclerosis 1982;44:61-71.
17. Kostner G, Klein G, Krempler F. Can serum Lp(a) concentration be lowered by drugs and/or diet? In: Carlson LA, Olsson AG, eds. Treat-ment of Hyperlipoproteinaemics. New York: Raven Press 1984;151-6.
18. Carlson LA, Hamsten A, Asplundl A. Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid. J Int Med 1989;226:271-6.
19. Kratzin H, Armstrong VW, Niehaus M, Hilschman N, Seidel D. Structural relationship of an apolipoprotein(a) phenotype to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. Biol Chem HoppesSeyler 1987;368:1533-44.
20. McClean J\V, Tomlinson JE, Kuang WJ, Eaton DL, Ellson YC, Gunther MF, Scanu AM, Lawn RM. A DNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987;330:132-7.
21. Scanu AM. Lipoprotein(a) a potential bridge between the fields of atherosclerosis and thrombosis. Arch Pathol Lab Med 1988;112: 1045-7.
22. Silberman S, Armentrout M, Vella F, Saha A. Macra Lp(a) for quantitation of human lipoprotein (a) by enzymes. Clin Chem 1990;36(#6): 961.
23. Rånby M. Lp(a): Strong hypervariable risk factor for atherosclerosis and cardiovascular disease. Clinical Hemostasis Review September, 1991;9-10.
24. Westgard JO, Hunt MR. Use and interpretation of common statistical tests in method-comparison studies. Clin Chem 1973; 19:49-57.
25. Lee J, Koh D, Ong CM. Statistical evaluation of agreement between two methods for measuring a quantitative variable. Comput Biol Med 1989; 19:61-70.
26. Bland JM, Altman DC. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-10.
27. Shapiro SS, Wilk MB: An analysis of variance test for normality (complete samples). Biometrika 1965;52:591-611.
28. Mann HB, Whitney DR. On a test of whether one of two random variables is stochastically larger than the other. Ann Math Statist 1947;18: 50-60.
29. Dagen MM, Packard CJ, Shepherd J. A comparison of commercial kits for movement of lipoprotein(a). Ann Clin Biochem 1991;28: 359-64.
30. Glueck CJ, McCray C, Speirs J. Measurement of serum apo Al and apo B: Comparison of immunoturbidimetric and rate nephelometric techniques. Clin Chim Acta 1991;197:123-32.